Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 28, 2017

The risk of unjustified BRCA testing after the “Angelina Jolie effect”: how can we save (laboratory) medicine from the Internet?

  • Giuseppe Lippi ORCID logo EMAIL logo

Corresponding author: Prof. Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37100 Verona, Italy

  1. Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Nelson HD, Fu R, Goddard K, Mitchell JP, Okinaka-Hu L, Pappas M, et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Dec. Report No.: 12-05164-EF-1.Search in Google Scholar

2. Li X, You R, Wang X, Liu C, Xu Z, Zhou J, et al. Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review. Clin Cancer Res 2016;22:3971–81.10.1158/1078-0432.CCR-15-1465Search in Google Scholar PubMed

3. McCarthy AM, Armstrong K. The role of testing for BRCA1 and BRCA2 mutations in cancer prevention. JAMA Intern Med 2014;174:1023–4.10.1001/jamainternmed.2014.1322Search in Google Scholar PubMed PubMed Central

4. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 2014;160:255–66.10.7326/M13-1684Search in Google Scholar PubMed

5. Neveling K, Mensenkamp AR, Derks R, Kwint M, Ouchene H, Steehouwer M, et al. BRCA testing by single-molecule molecular inversion probes. Clin Chem 2017;63:503–12.10.1373/clinchem.2016.263897Search in Google Scholar PubMed

6. Watson ID, Siodmiak J, Oosterhuis WP, Corberand J, Jorgensen PE, Dikm en ZG, et al. European views on patients directly obtaining their laboratory test results. Clin Chem Lab Med 2015;53:1961–6.10.1515/cclm-2015-0056Search in Google Scholar PubMed

7. Lippi G. Popularity of Medicine and Laboratory Medicine journals: analysis of impact factor and popularity using Google Trends. J Lab Precis Med 2017;2:28.10.21037/jlpm.2017.06.08Search in Google Scholar

8. Lippi G, Mattiuzzi C, Montagnana M. BRCA population screening for predicting breast cancer: for or against? Ann Transl Med 2017;5:275.10.21037/atm.2017.06.71Search in Google Scholar PubMed PubMed Central

Received: 2017-06-26
Accepted: 2017-07-01
Published Online: 2017-07-28
Published in Print: 2018-01-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 25.9.2023 from
Scroll to top button